Načítá se...
Phase 2a Clinical Trial of Mitochondrial Protection (Elamipretide) During Stent Revascularization in Patients with Atherosclerotic Renal Artery Stenosis
BACKGROUND: Atherosclerotic renal artery stenosis (ARAS) reduces renal blood flow (RBF) and amplifies stenotic kidney (SK) hypoxia. Revascularization with percutaneous transluminal renal angioplasty and stenting (PTRA) often fails to recover renal function possibly due to ischemia reperfusion injury...
Uloženo v:
Vydáno v: | Circ Cardiovasc Interv |
---|---|
Hlavní autoři: | , , , , , , , , , |
Médium: | Artigo |
Jazyk: | Inglês |
Vydáno: |
2017
|
Témata: | |
On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5659347/ https://ncbi.nlm.nih.gov/pubmed/28916603 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCINTERVENTIONS.117.005487 |
Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|